Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Corbin

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Blood|September 13, 2011
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemiaThomas O'Hare, Matthew S Zabriskie, Christopher A Eide, et al.
Advances in Radiation Oncology|June 1, 2022
Intensity Modulated Proton Therapy for Bilateral Breast or Chest Wall and Comprehensive Nodal Irradiation for Synchronous Bilateral Breast Cancer: Initial Clinical Experience and Dosimetric ComparisonAllison E Garda, Ashley E Hunzeker, Ann K Michel, et al.
Practical Radiation Oncology|December 26, 2024
Highs and Lows of Spatially Fractionated Radiation Therapy: Dosimetry and Clinical OutcomesDawn Owen, W Scott Harmsen, Safia K Ahmed, et al.
Cancer Research|July 27, 2013
KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitorsAmie S Corbin, Thomas O'Hare, Zhimin Gu, et al.
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
Alzheimer Disease and Associated Disorders|January 23, 1998
Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controlsE R Peskind, J Leverenz, M R Farlow, et al.
Blood|March 5, 2005
In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of KitAmie S Corbin, Shadmehr Demehri, Ian J Griswold, et al.
BMC Health Services Research|March 19, 2021
A feasibility study using time-driven activity-based costing as a management tool for provider cost estimation: lessons from the national TB control program in Zimbabwe in 2018J Chirenda, B Nhlema Simwaka, C Sandy, et al.
Practical Radiation Oncology|September 9, 2019
Incorporation of Biologic Response Variance Modeling Into the Clinic: Limiting Risk of Brachial Plexopathy and Other Late Effects of Breast Cancer Proton Beam TherapyRobert W Mutter, Krishan R Jethwa, Hok Seum Wan Chan Tseung, et al.
Acta Oncologica (Stockholm, Sweden)|October 2, 2024
Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparisonJessica F Burlile, Satomi Shiraishi, Heather J Gunn, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Blood|September 13, 2011
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemiaThomas O'Hare, Matthew S Zabriskie, Christopher A Eide, et al.
Advances in Radiation Oncology|June 1, 2022
Intensity Modulated Proton Therapy for Bilateral Breast or Chest Wall and Comprehensive Nodal Irradiation for Synchronous Bilateral Breast Cancer: Initial Clinical Experience and Dosimetric ComparisonAllison E Garda, Ashley E Hunzeker, Ann K Michel, et al.
Practical Radiation Oncology|December 26, 2024
Highs and Lows of Spatially Fractionated Radiation Therapy: Dosimetry and Clinical OutcomesDawn Owen, W Scott Harmsen, Safia K Ahmed, et al.
Cancer Research|July 27, 2013
KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitorsAmie S Corbin, Thomas O'Hare, Zhimin Gu, et al.
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
Alzheimer Disease and Associated Disorders|January 23, 1998
Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controlsE R Peskind, J Leverenz, M R Farlow, et al.
Blood|March 5, 2005
In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of KitAmie S Corbin, Shadmehr Demehri, Ian J Griswold, et al.
BMC Health Services Research|March 19, 2021
A feasibility study using time-driven activity-based costing as a management tool for provider cost estimation: lessons from the national TB control program in Zimbabwe in 2018J Chirenda, B Nhlema Simwaka, C Sandy, et al.
Practical Radiation Oncology|September 9, 2019
Incorporation of Biologic Response Variance Modeling Into the Clinic: Limiting Risk of Brachial Plexopathy and Other Late Effects of Breast Cancer Proton Beam TherapyRobert W Mutter, Krishan R Jethwa, Hok Seum Wan Chan Tseung, et al.
Acta Oncologica (Stockholm, Sweden)|October 2, 2024
Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparisonJessica F Burlile, Satomi Shiraishi, Heather J Gunn, et al.
Pageof 13